Exanthema and eosinophilia in COVID-19 patients: has viral infection a role in drug induced exanthemas?
作者信息
Rosell-Díaz A M, Mateos-Mayo A, Nieto-Benito L M, Balaguer-Franch I, Hernández de la Torre-Ruiz E, Lainez-Nuez A, Suárez-Fernández R, Bergón-Sendín M
机构信息
Dermatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Allergology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
出版信息
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e561-e563. doi: 10.1111/jdv.16709. Epub 2020 Jun 30.
Abstract
摘要
相似文献
1
Exanthema and eosinophilia in COVID-19 patients: has viral infection a role in drug induced exanthemas?
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e561-e563. doi: 10.1111/jdv.16709. Epub 2020 Jun 30.
2
COVID-19: Stay Cool toward Corticosteroids.
Keio J Med. 2020 Jun 25;69(2):27-29. doi: 10.2302/kjm.2020-0007-LE. Epub 2020 May 30.
3
Incidence of Adverse Drug Reactions in COVID-19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System.
Clin Pharmacol Ther. 2020 Oct;108(4):791-797. doi: 10.1002/cpt.1866. Epub 2020 May 26.
4
Papular-purpuric exanthem in a COVID-19 patient: clinical and dermoscopic description.
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e570-e572. doi: 10.1111/jdv.16732. Epub 2020 Jun 29.
5
Take precautions beforehand: calling for clinical trials of pediatric drugs for treating coronavirus disease 2019.
World J Pediatr. 2020 Jun;16(3):275-277. doi: 10.1007/s12519-020-00355-3. Epub 2020 Mar 25.
6
Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not 'varicella-like'.
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e559-e561. doi: 10.1111/jdv.16706. Epub 2020 Jul 2.
7
Lessons from the Italian COVID-19 frontline.
Minerva Med. 2020 Aug;111(4):303-305. doi: 10.23736/S0026-4806.20.06664-1.
8
Follicular eruption as a cutaneous manifestation in COVID-19.
BMJ Case Rep. 2020 Oct 29;13(10):e238182. doi: 10.1136/bcr-2020-238182.
9
Impact of the COVID-19 pandemic in children with allergic asthma.
J Allergy Clin Immunol Pract. 2020 Oct;8(9):3172-3174.e1. doi: 10.1016/j.jaip.2020.07.019. Epub 2020 Jul 27.
10
COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
Am J Ophthalmol. 2020 May;213:A3-A4. doi: 10.1016/j.ajo.2020.03.028. Epub 2020 Mar 25.
引用本文的文献
1
The role of treatment with plasma exchange therapy in two pediatric toxic epidermal necrolysis cases related to COVID-19.
J Clin Apher. 2022 Oct;37(5):516-521. doi: 10.1002/jca.21997. Epub 2022 Jul 6.
2
Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS.
Biomedicines. 2022 Apr 26;10(5):999. doi: 10.3390/biomedicines10050999.
3
Erythema multiforme in COVID-19 patients and following COVID-19 vaccination: manifestations, associations and outcomes.
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e524-e530. doi: 10.1111/jdv.18063. Epub 2022 Mar 21.
4
Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease.
Viruses. 2021 Aug 24;13(9):1675. doi: 10.3390/v13091675.
5
Cutaneous Manifestations of COVID-19 in the Inpatient Setting.
Dermatol Clin. 2021 Oct;39(4):521-532. doi: 10.1016/j.det.2021.05.011. Epub 2021 May 28.
6
Virology and Etiopathogenesis of COVID-19 with Special Reference to Cutaneous Implications.
Indian J Dermatol. 2021 May-Jun;66(3):231-236. doi: 10.4103/ijd.ijd_467_21.
7
Severe and life-threatening COVID-19-related mucocutaneous eruptions: A systematic review.
Int J Clin Pract. 2021 Dec;75(12):e14720. doi: 10.1111/ijcp.14720. Epub 2021 Sep 28.
8
Synthesis of the Data on COVID-19 Skin Manifestations: Underlying Mechanisms and Potential Outcomes.
Clin Cosmet Investig Dermatol. 2021 Aug 6;14:991-997. doi: 10.2147/CCID.S325552. eCollection 2021.
9
Maculopapular skin eruptions associated with Covid-19: A systematic review.
Dermatol Ther. 2021 Mar;34(2):e14788. doi: 10.1111/dth.14788. Epub 2021 Feb 2.
10
Cutaneous Manifestations in Confirmed COVID-19 Patients: A Systematic Review.
Biology (Basel). 2020 Dec 5;9(12):449. doi: 10.3390/biology9120449.
本文引用的文献
1
Cutaneous manifestations in COVID-19: a first perspective.
J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213. doi: 10.1111/jdv.16387.
2
COVID-19: consider cytokine storm syndromes and immunosuppression.
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
3
A case of an acute cutaneous drug reaction with hydroxychloroquine.
Scott Med J. 2018 Aug;63(3):91-94. doi: 10.1177/0036933018763277. Epub 2018 Mar 7.
4
A complex interaction between drug allergy and viral infection.
Clin Rev Allergy Immunol. 2007 Oct;33(1-2):124-33. doi: 10.1007/s12016-007-8010-9.
5
Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses.
Allergol Int. 2006 Mar;55(1):1-8. doi: 10.2332/allergolint.55.1.
Zotero 插件